The United States Food and Drug Administration (FDA) has issued an update on its efforts to engage patients in its regulatory approval processes. The FDA believes that involving the end-user – the patient – in identifying health priorities and outcomes desired from health interventions is critically important. This requires cultures and processes that ensure routine integration of these patient perspectives at each key stage of product development. To read the FDA update on its efforts to engage patients in its regulatory approval processes, use the link below.
You are here
October 11, 2017